These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29194085)
1. Breath Volatile Organic Compound Profiling of Colorectal Cancer Using Selected Ion Flow-tube Mass Spectrometry. Markar SR; Chin ST; Romano A; Wiggins T; Antonowicz S; Paraskeva P; Ziprin P; Darzi A; Hanna GB Ann Surg; 2019 May; 269(5):903-910. PubMed ID: 29194085 [TBL] [Abstract][Full Text] [Related]
2. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study. Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578 [No Abstract] [Full Text] [Related]
3. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615 [TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255 [TBL] [Abstract][Full Text] [Related]
5. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up. Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677 [TBL] [Abstract][Full Text] [Related]
6. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results. De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489 [TBL] [Abstract][Full Text] [Related]
7. Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer. Markar SR; Brodie B; Chin ST; Romano A; Spalding D; Hanna GB Br J Surg; 2018 Oct; 105(11):1493-1500. PubMed ID: 30019405 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study. Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer detection using volatile compound profiles in exhaled breath via selected ion-flow tube mass spectrometry. Nakayama Y; Hanada M; Koda H; Sugimoto M; Takada M; Toi M J Breath Res; 2022 Dec; 17(1):. PubMed ID: 36541460 [TBL] [Abstract][Full Text] [Related]
10. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180 [TBL] [Abstract][Full Text] [Related]
11. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis. Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264 [TBL] [Abstract][Full Text] [Related]
12. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
13. Pioneering noninvasive colorectal cancer detection with an AI-enhanced breath volatilomics platform. Liu Y; Ji Y; Chen J; Zhang Y; Li X; Li X Theranostics; 2024; 14(11):4240-4255. PubMed ID: 39113791 [No Abstract] [Full Text] [Related]
14. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now? Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400 [TBL] [Abstract][Full Text] [Related]
15. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
16. Status of selected ion flow tube MS: accomplishments and challenges in breath analysis and other areas. Smith D; Španěl P Bioanalysis; 2016 Jun; 8(11):1183-201. PubMed ID: 27212131 [TBL] [Abstract][Full Text] [Related]
17. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Oakley-Girvan I; Davis SW Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925 [TBL] [Abstract][Full Text] [Related]
18. Selected ion flow tube mass spectrometry for targeted analysis of volatile organic compounds in human breath. Belluomo I; Boshier PR; Myridakis A; Vadhwana B; Markar SR; Spanel P; Hanna GB Nat Protoc; 2021 Jul; 16(7):3419-3438. PubMed ID: 34089020 [TBL] [Abstract][Full Text] [Related]
19. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of colorectal cancer by analysis of exhaled breath. Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]